CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it will be hosting a virtual RNAi Roundtable on Thursday, March 4, 2010 from 12:00 p.m. – 1:00 p.m. ET focused on recent progress with systemic delivery of RNAi Therapeutics.
